Verus Capital Partners LLC Invests $260,000 in Axon Enterprise, Inc. (NASDAQ:AXON)

Verus Capital Partners LLC bought a new position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 650 shares of the biotechnology company’s stock, valued at approximately $260,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Sumitomo Mitsui Trust Group Inc. increased its position in Axon Enterprise by 2.5% during the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 159,322 shares of the biotechnology company’s stock worth $63,665,000 after purchasing an additional 3,924 shares in the last quarter. Patron Partners LLC acquired a new stake in Axon Enterprise during the 3rd quarter worth approximately $209,000. GSA Capital Partners LLP increased its position in Axon Enterprise by 61.2% during the 3rd quarter. GSA Capital Partners LLP now owns 1,736 shares of the biotechnology company’s stock worth $694,000 after purchasing an additional 659 shares in the last quarter. Apollon Wealth Management LLC increased its position in Axon Enterprise by 11.3% during the 3rd quarter. Apollon Wealth Management LLC now owns 1,304 shares of the biotechnology company’s stock worth $521,000 after purchasing an additional 132 shares in the last quarter. Finally, Versor Investments LP acquired a new stake in Axon Enterprise in the third quarter valued at approximately $651,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have issued reports on the stock. Northland Securities increased their price objective on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research report on Monday. Barclays increased their price objective on shares of Axon Enterprise from $381.00 to $387.00 and gave the company an “overweight” rating in a research report on Wednesday, August 7th. Robert W. Baird increased their price objective on shares of Axon Enterprise from $440.00 to $460.00 and gave the company an “outperform” rating in a research report on Monday, November 4th. Needham & Company LLC increased their price objective on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research report on Friday, November 8th. Finally, Jefferies Financial Group assumed coverage on shares of Axon Enterprise in a research report on Wednesday, July 17th. They issued a “buy” rating and a $385.00 price objective for the company. Two research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $427.83.

Axon Enterprise Stock Performance

Shares of AXON opened at $601.29 on Thursday. The business’s fifty day moving average price is $428.90 and its 200 day moving average price is $353.54. Axon Enterprise, Inc. has a 12-month low of $220.51 and a 12-month high of $624.84. The stock has a market capitalization of $45.85 billion, a PE ratio of 155.37, a price-to-earnings-growth ratio of 14.95 and a beta of 0.94. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, President Joshua Isner sold 20,000 shares of the firm’s stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $606.15, for a total value of $12,123,000.00. Following the sale, the president now directly owns 208,166 shares in the company, valued at approximately $126,179,820.90. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In other Axon Enterprise news, President Joshua Isner sold 20,000 shares of the firm’s stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $606.15, for a total value of $12,123,000.00. Following the sale, the president now directly owns 208,166 shares in the company, valued at approximately $126,179,820.90. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Michael Garnreiter sold 1,000 shares of the firm’s stock in a transaction on Tuesday, October 15th. The shares were sold at an average price of $437.98, for a total value of $437,980.00. Following the completion of the sale, the director now owns 26,259 shares in the company, valued at $11,500,916.82. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 389,172 shares of company stock worth $148,393,842. 6.10% of the stock is owned by insiders.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.